High Point Advisor Group LLC Astrazeneca PLC Transaction History
High Point Advisor Group LLC
- $1.4 Billion
- Q1 2024
A detailed history of High Point Advisor Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, High Point Advisor Group LLC holds 27,874 shares of AZN stock, worth $2.15 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
27,874
Previous 20,536
35.73%
Holding current value
$2.15 Million
Previous $1.38 Million
36.51%
% of portfolio
0.14%
Previous 0.11%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,247Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.72 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.78 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...